reference/25661654

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25661654

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't\|Review
endingPage	928
issn	1465-6566 1744-7666
issueIdentifier	6
pageRange	913-928
publicationName	Expert Opinion on Pharmacotherapy
startingPage	913
bibliographicCitation	Bousquet J, Bachert C, Bernstein J, Canonica GW, Carr W, Dahl R, Demoly P, Devillier P, Hellings P, Fokkens W, Klimek L, Lieberman P, Meltzer E, Price D, Ryan D, Wahn U. Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps. Expert Opin Pharmacother. 2015 Apr;16(6):913–28. doi: 10.1517/14656566.2015.1020789. PMID: 25747125.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60656c373da6fafbef092f5282898c1a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0c5321e48b1d911c2c274ecaedda4e80 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1255b98d22c66004177a7ce8604d52e3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c82a875618ad7a6b0a4be1d48f370a20 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b87a4c2f3d88f1c335c3adf3d60414c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7827-7964 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2423caf926c0fdf26dc456ac55b8ce77 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_060ed4eaef1f7e34b22eb85ffd8ae0f8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dc1fab37b4c9d9b025f9f756fa202435 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6898-688X http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4115-7376 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef771695876af4759daf824dac3ce515 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0299216f550608cde54a738444f50574 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72cd49555fa747a6d55b16f44c6d1072 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5a0602dead823f7dc935a2786135543 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a77de5b48b2ce629458cfd17e80dc89 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b25e1e9816f2470516ca3e73487163e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e26aa3c47d424f8dc5773bdc4c199f4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_698e2a619cb710af5fb7bfafa11da740 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3476-1196
date	2015-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/25747125 https://doi.org/10.1517/14656566.2015.1020789
isPartOf	https://portal.issn.org/resource/ISSN/1465-6566 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/22235 https://portal.issn.org/resource/ISSN/1744-7666
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps
discusses	http://id.nlm.nih.gov/mesh/M0075361 http://id.nlm.nih.gov/mesh/M0006823 http://id.nlm.nih.gov/mesh/M0575703 http://id.nlm.nih.gov/mesh/M0001108 http://id.nlm.nih.gov/mesh/M0016766 http://id.nlm.nih.gov/mesh/M0028295
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000730Q000627 http://id.nlm.nih.gov/mesh/D018926Q000627 http://id.nlm.nih.gov/mesh/D010793Q000627 http://id.nlm.nih.gov/mesh/D065631Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D010793Q000493 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D010793Q000009 http://id.nlm.nih.gov/mesh/D004338 http://id.nlm.nih.gov/mesh/D018926Q000493 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D006255Q000188 http://id.nlm.nih.gov/mesh/D012221Q000188 http://id.nlm.nih.gov/mesh/D000281 http://id.nlm.nih.gov/mesh/D000730Q000493 http://id.nlm.nih.gov/mesh/D000730Q000009 http://id.nlm.nih.gov/mesh/D018926Q000009
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7904 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11478 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54360 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444036 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9112 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9897697

Total number of triples: 67.